Anest Iwata Corp. · TSE:6381
Anest Iwata — Q3 FY2021 Earnings Presentation
11 slides from Anest Iwata's earnings presentation, Feb 10, 2022
Slide 1: Supplementary Presentation Material of FY2021 Third Quarter Financial Results
Supplementary Presentation Material of FY2021 Third Quarter Financial Results ANEST IWATA Corporation February 10, 2022 First Section of the Tokyo Stock Exchange - Machinery Securities Code 6381
Slide 2: FY2021 3Q financial highlights
FY2021 3Q financial highlights Overseas markets contributed to increases in the sales of both general -purpose and customized products. Coupled with the cost control through the work reform accelerated by the COVID -19 pandemic, these markets helped us achieve continuous increases in sales and incom
Slide 3: Highlights of FY2021 3Q financial results
Highlights of FY2021 3Q financial results As in the 2nd quarter, income exceeded the pre-COVID levels.＊1 The U.S., European, Chinese, and Indian markets led increases in sales. The impact of fluctuations in foreign exchange rates was 1.1 billion yen. The increase in the operating income ratio was du
Slide 4: Analysis of causes of operating income increase/decrease
Analysis of causes of operating income increase/decrease The growth in sales compensated for the cost increase resulting from increased activities, contributing to the rise in income. [+] Increase in sales: 30,229 million yen (up 4,717 million yen from last year) [+] Improvement in cost-to-sales rat
Slide 5: Sales by area and by product
Sales by area and by product Sales of general-purpose products grew as the economy recovered in Asia and other areas, excluding the ASEAN region. ・Japan: While the delayed supply of compressor motors impacted us in October, our business slowly recovered after that, except for coating systems. As for
Slide 6: Prospects for FY2021
Prospects for FY2021 The prospects for the full year and dividend forecasts remain unchanged. Amount: million yen FY2020 (Actual) FY2021 (Prospect) Actual Composition Beginning-of- Revised forecast Composition As compared Year-on-year ratio term forecast (announced on ratio with the initial ％ (annou
Slide 7: Capital investment plan and R&D cost
Capital investment plan and R&D cost <The projected amount of capital investment was revised.> (Actual) 3Q: Amount of capital investment 44.1%, R&D cost 68.2% IT-related investments: The annual investment amount, such as the construction of work reform-related systems, improving networks, etc. , is
Slide 8: Reference information: Details of profit and loss statements
<Reference information> Details of profit and loss statements A substantial increase in sales brought the cost-to-sales ratio down. The work reform kept costs under control, leading to a drop in the selling, general & administrative expenses ratio. The operating income ratio rose by 2 points. FY2020
Slide 9: Reference information: FY2021 3Q Changes in business results
<Reference information> FY2021 3Q Changes in business results [Total] [Quarterly] Amount: million yen FY2021 Amount: million yen FY2021 1Q 2Q 3Q 1Q 2Q 3Q Sales 9,100 20,360 30,229 Sales 9,100 11,259 9,869 Year-on-year 31.6% 23.2% 18.5% Year-on-year 31.6% 17.1% 9.9% Air compressor 5,061 11,199 16,889
Slide 10: Reference information: History of our business
<Reference information> History of our business We started by manufacturing coating spray guns and air compressors for inspecting those guns. Founded in 1926 (Former company name: Iwata Seisakusho) Product differentiation concept ・Environment-friendly ・Ability to present Started manufacturing of spr
Slide 11: Notes on the descriptions about future prospects and other matters
Notes on the descriptions about future prospects and other matters The future prospects for our company mentioned in this document are based on the currently available information. Please be advised that there are various external factors that can impact our business performance, such as the global